XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Cash flows from operating activities:    
Net income $ 38,033 $ 35,996
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation of property, plant, and equipment 13,905 14,799
Amortization of intangible assets 929 939
Provision for (recoveries of) excess and obsolete inventory, net 2,026 (1,256)
Gain on partial termination of corporate lease 0 (4,366)
Other asset impairments and loss on disposal of property, plant and equipment, net of recoveries (1) 2,632
Amortization of debt issuance costs 403 393
Stock-based compensation expense 5,170 4,343
Unrealized foreign currency exchange loss (gain), net 9 (240)
Provisions for doubtful accounts receivable from customers 561 235
Unrealized gain on investments (618) (433)
Deferred income taxes 6,811 5,031
Effect of changes in operating assets and liabilities:    
Accounts receivable (40,746) (24,944)
Finished goods inventories 61,039 134,147
Prepaid expenses and other assets (22,386) (12,678)
Accounts payable and other liabilities (90,686) (112,401)
Net cash (used in) provided by operating activities (25,551) 42,197
Cash flows from investing activities:    
Capital expenditures (12,017) (13,827)
Net cash used in investing activities (12,017) (13,827)
Cash flows from financing activities:    
Payments on secured revolving credit facility 0 (40,000)
Repurchases of common stock (8,999) (9,586)
Dividends paid (29,338) (28,483)
Withholdings from vesting of restricted stock (7,378) (4,776)
Proceeds from exercises of stock options 367 83
Net cash used in financing activities (45,348) (82,762)
Net effect of exchange rate changes on cash and cash equivalents (722) 329
Net decrease in cash and cash equivalents (83,638) (54,063)
Cash and cash equivalents, beginning of period 351,213 211,748
Cash and cash equivalents, end of period $ 267,575 $ 157,685